生命科学资讯

10x Genomics (NASDAQ:TXG) Delivers Impressive Q4 CY2025 - Yahoo Finance

10x Genomics (NASDAQ:TXG) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat

10x Genomics: Q4 Earnings Snapshot - WKYC

10x Genomics (NASDAQ: TXG) narrows 2025 losses and guides to modest 2026 growth - Stock Titan

10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026 - PR Newswire

10X Genomics faces earnings test as new pricing strategy debuts - Investing.com

10x Genomics PharosAI Cancer Project Tests Xenium’s Long Term Investment Case - Yahoo Finance

Assessing 10x Genomics (TXG) Valuation After Earnings Anticipation And New PharosAI Cancer Research Collaboration - Yahoo Finance

UK-Backed PharosAI Cancer Data Project Using Xenium Might Change The Case For Investing In 10x Genomics (TXG) - Yahoo Finance

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect - Finviz

10x Genomics (TXG) reports earnings tomorrow: What to expect - MSN

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect - Yahoo Finance

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect - The Chronicle-Journal

10x Genomics gets injunction against Parse Biosciences' ATAC Products - MSN

10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - MSN

Is 10x Genomics (TXG) Using PharosAI’s NHS Partnership To Quietly Recast Its Spatial Biology Moat? - simplywall.st

10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Finviz

10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo! Finance Canada